Inflammatory signal transduction from the FcεRI to NF-κB

Immunobiology

Volumn 211, Issue 10, 2006, Pages 815-820

  Klemm, Stefanie ^a   Ruland, Jürgen ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Bcl10; Fc lunate RI; Inflammation; Malt1; Mast cells; NF B

Indexed keywords

CYTOKINE; FC RECEPTOR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOENZYME; LEUKOTRIENE; PROTEIN BCL 10; PROTEIN KINASE C; TRANSCRIPTION FACTOR;

ALLERGIC DISEASE; CELL ACTIVATION; CROSS LINKING; CYTOKINE PRODUCTION; GENE ACTIVATION; IMMUNE RESPONSE; INFLAMMATION; MAST CELL; MAST CELL DEGRANULATION; MEDIATOR RELEASE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

EID: 33750934389     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2006.07.001     Document Type: Review

References (47)

1. Akagi T., Motegi M., Tamura A., Suzuki R., Hosokawa Y., Suzuki H., Ota H., Nakamura S., Morishima Y., Taniwaki M., and Seto M. A novel gene, MALT1 at 18q21, is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue. Oncogene 18 (1999) 5785-5794
2. Azzolina A., Bongiovanni A., and Lampiasi N. Substance P induces TNF-alpha and IL-6 production through NF kappa B in peritoneal mast cells. Biochim. Biophys. Acta 1643 (2003) 75-83
3. Cho S.H., Woo C.H., Yoon S.B., and Kim J.H. Protein kinase Cdelta functions downstream of Ca2+ mobilization in FcepsilonRI signaling to degranulation in mast cells. J. Allergy Clin. Immunol. 114 (2004) 1085-1092
4. Dierlamm J., Baens M., Wlodarska I., Stefanova-Ouzounova M., Hernandez J.M., Hossfeld D.K., De Wolf-Peeters C., Hagemeijer A., Van den Berghe H., and Marynen P. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21)p6ssociated with mucosa-associated lymphoid tissue lymphomas. Blood 93 (1999) 3601-3609
5. Galli S.J., Kalesnikoff J., Grimbaldeston M.A., Piliponsky A.M., Williams C.M., and Tsai M. Mast cells as "tunable" effector and immunoregulatory cells: Recent avances. Annu. Rev. Immunol. 23 (2005) 749-786
6. Galli S.J., Nakae S., and Tsai M. Mast cells in the development of adaptive immune responses. Nat. Immunol. 6 (2005) 135-142
7. Gilfillan A.M., and Tkaczyk C. Integrated signalling pathways for mast-cell activation. Nat. Rev. Immunol. 6 (2006) 218-230
8. Inagaki N., Goto S., Nagai H., and Koda A. Homologous passive cutaneous anaphylaxis in various strains of mice. Int. Arch. Allergy Appl. Immunol. 81 (1986) 58-62
9. Inagaki N., Goto S., Yamasaki M., Nagai H., and Koda A. Studies on vascular permeability increasing factors involved in 48-hour homologous PCA in the mouse ear. Int. Arch. Allergy Appl. Immunol. 80 (1986) 285-290
10. Kalesnikoff J., Baur N., Leitges M., Hughes M.R., Damen J.E., Huber M., and Krystal G. SHIP negatively regulates IgE+antigen-induced IL-6 production in mast cells by inhibiting NF-kappa B activity. J. Immunol. 168 (2002) 4737-4746
11. Karin M. NF-kappaB and cancer: mechanisms and targets. Mol. Carcinog. 45 (2006) 355-361
12. Karin M., and Greten F.R. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 5 (2005) 749-759
13. Karin M., Yamamoto Y., and Wang Q.M. The IKK NF-kappaB system: a treasure trove for drug development. Nat. Rev. Drug Discov. 3 (2004) 17-26
14. Kawakami Y., Kitaura J., Hartman S.E., Lowell C.A., Siraganian R.P., and Kawakami T. Regulation of protein kinase CbetaI by two protein-tyrosine kinases, Btk and Syk. Proc. Natl. Acad. Sci. USA 97 (2000) 7423-7428
15. Klemm S., Gutermuth J., Hultner L., Sparwasser T., Behrendt H., Peschel C., Mak T.W., Jakob T., and Ruland J. The Bcl10-Malt1 complex segregates Fc{epsilon}RI-mediated nuclear factor {kappa}B activation and cytokine production from mast cell degranulation. J. Exp. Med. 203 (2006) 337-347
16. Koseki T., Inohara N., Chen S., Carrio R., Merino J., Hottiger M.O., Nabel G.J., and Nunez G. CIPER, a novel NF kappaB-activating protein containing a caspase recruitment domain with homology to Herpesvirus-2 protein E10. J. Biol. Chem. 274 (1999) 9955-9961
17. Li Q., and Verma I.M. NF-kappaB regulation in the immune system. Nat. Rev. Immunol. 2 (2002) 725-734
18. Liu Y., Graham C., Parravicini V., Brown M.J., Rivera J., and Shaw S. Protein kinase C theta is expressed in mast cells and is functionally involved in Fcepsilon receptor I signaling. J. Leukoc. Biol. 69 (2001) 831-840
19. Lucas P.C., Yonezumi M., Inohara N., McAllister-Lucas L.M., Abazeed M.E., Chen F.F., Yamaoka S., Seto M., and Nunez G. Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway. J. Biol. Chem. 276 (2001) 19012-19019
20. Marquardt D.L., and Walker L.L. Dependence of mast cell IgE-mediated cytokine production on nuclear factor-kappaB activity. J. Allergy Clin. Immunol. 105 (2000) 500-505
21. Matsumoto R., Wang D., Blonska M., Li H., Kobayashi M., Pappu B., Chen Y., and Lin X. Phosphorylation of CARMA1 plays a critical role in T Cell receptor-mediated NF-kappaB activation. Immunity 23 (2005) 575-585
22. Mekori Y.A., and Metcalfe D.D. Mast cells in innate immunity. Immunol. Rev. 173 (2000) 131-140
23. Metcalfe D.D., Baram D., and Mekori Y.A. Mast cells. Physiol. Rev. 77 (1997) 1033-1079
24. Metzger H. The high affinity receptor for IgE on mast cells. Clin. Exp. Allergy 21 (1991) 269-279
25. Nakae S., Suto H., Kakurai M., Sedgwick J.D., Tsai M., and Galli S.J. Mast cells enhance T cell activation: Importance of mast cell-derived TNF. Proc. Natl. Acad. Sci. USA 102 (2005) 6467-6472
26. Peng Y., Power M.R., Li B., and Lin T.J. Inhibition of IKK down-regulates antigen+IgE-induced TNF production by mast cells: a role for the IKK-I{kappa}B-NF-{kappa}B pathway in IgE-dependent mast cell activation. J. Leukoc. Biol. 77 (2005) 975-983
27. Rajkumar S.V., Richardson P.G., Hideshima T., and Anderson K.C. Proteasome inhibition as a novel therapeutic target in human cancer. J. Clin. Oncol. 23 (2005) 630-639
28. Rottem M., and Mekori Y.A. Mast cells and autoimmunity. Autoimmun. Rev. 4 (2005) 21-27
29. Ruland J., Duncan G.S., Elia A., del Barco Barrantes I., Nguyen L., Plyte S., Millar D.G., Bouchard D., Wakeham A., Ohashi P.S., and Mak T.W. Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kappaB and neural tube closure. Cell 104 (2001) 33-42
30. Ruland J., Duncan G.S., Wakeham A., and Mak T.W. Differential requirement for Malt1 in T and B cell antigen receptor signaling. Immunity 19 (2003) 749-758
31. Siraganian R.P. Mast cell signal transduction from the high-affinity IgE receptor. Curr. Opin. Immunol. 15 (2003) 639-646
32. Sommer K., Guo B., Pomerantz J.L., Bandaranayake A.D., Moreno-Garcia M.E., Ovechkina Y.L., and Rawlings D.J. Phosphorylation of the CARMA1 linker controls NF-kappaB activation. Immunity 23 (2005) 561-574
33. Srinivasula S.M., Ahmad M., Lin J.H., Poyet J.L., Fernandes-Alnemri T., Tsichlis P.N., and Alnemri E.S. CLAP, a novel caspase recruitment domain-containing protein in the tumor necrosis factor receptor pathway, regulates NF-kappaB activation and apoptosis. J. Biol. Chem. 274 (1999) 17946-17954
34. Su T.T., Guo B., Kawakami Y., Sommer K., Chae K., Humphries L.A., Kato R.M., Kang S., Patrone L., Wall R., Teitell M., Leitges M., Kawakami T., and Rawlings D.J. PKC-beta controls I kappa B kinase lipid raft recruitment and activation in response to BCR signaling. Nat. Immunol. 3 (2002) 780-786
35. Sun L., Deng L., Ea C.K., Xia Z.P., and Chen Z.J. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol. Cell 14 (2004) 289-301
36. Tan S.L., and Parker P.J. Emerging and diverse roles of protein kinase C in immune cell signalling. Biochem. J. 376 (2003) 545-552
37. Thome M. CARMA1, BCL-10 and MALT1 in lymphocyte development and activation. Nat. Rev. Immunol. 4 (2004) 348-359
38. Turner H., and Kinet J.P. Signalling through the high-affinity IgE receptor Fc epsilonRI. Nature 402 (1999) B24-B30
39. Uren A.G., O'Rourke K., Aravind L.A., Pisabarro M.T., Seshagiri S., Koonin E.V., and Dixit V.M. Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. Mol. Cell 6 (2000) 961-967
40. von Bubnoff D., Novak N., Kraft S., and Bieber T. The central role of FcepsilonRI in allergy. Clin. Exp. Dermatol. 28 (2003) 184-187
41. Wang Y., and Thorlacius H. Mast cell-derived tumour necrosis factor-alpha mediates macrophage inflammatory protein-2-induced recruitment of neutrophils in mice. Br. J. Pharmacol. 145 (2005) 1062-1068
42. Wershil B.K., Wang Z.S., Gordon J.R., and Galli S.J. Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent. Partial inhibition of the reaction with antiserum against tumor necrosis factor-alpha. J. Clin. Invest. 87 (1991) 446-453
43. Willis T.G., Jadayel D.M., Du M.Q., Peng H., Perry A.R., Abdul-Rauf M., Price H., Karran L., Majekodunmi O., Wlodarska I., Pan L., Crook T., Hamoudi R., and Isaacson P.G. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 96 (1999) 35-45
44. Zavrski I., Jakob C., Schmid P., Krebbel H., Kaiser M., Fleissner C., Rosche M., Possinger K., and Sezer O. Proteasome: an emerging target for cancer therapy. Anticancer Drugs 16 (2005) 475-481
45. Zhang Q., Siebert R., Yan M., Hinzmann B., Cui X., Xue L., Rakestraw K.M., Naeve C.W., Beckmann G., Weisenburger D.D., Sanger W.G., Nowotny H., Vesely M., Callet-Bauchu E., Salles G., Dixit V.M., Rosenthal A., Schlegelberger B., and Morris S.W. Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32). Nat. Genet. 22 (1999) 63-68
46. Zhou H., Wertz I., O'Rourke K., Ultsch M., Seshagiri S., Eby M., Xiao W., and Dixit V.M. Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO. Nature 427 (2004) 167-171
47. Zhou H., Du M.Q., and Dixit V.M. Constitutive NF-kappaB activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity. Cancer Cell 7 (2005) 425-431